资讯

The drug, Acetaminophen Tablets (325 mg), is being recalled due to manufacturing deviations from Current Good Manufacturing ...
US-based unit of the drug major is recalling Acetaminophen Tablets (325 mg) in the US due to cGMP (Current Good Manufacturing ...
Aurobindo Pharma is recalling over 4,600 bottles of a pain relieving drug in the US market due to manufacturing issues, ...
Aurobindo Pharma recalls 4,608 bottles of Acetaminophen Tablets in the US due to manufacturing issues and tablet ...
MANHATTAN (CN) — A consumer class on Thursday asked a Second Circuit panel to renew claims that Tylenol misled them by charging more for “rapid release” capsules advertised as offering faster pain ...
Dabigatran etexilate is a pro-drug, undergoing rapid ester hydrolysis to its active moiety, dabigatran, with no significant CYP 450 metabolism. 1,115 After oral administration, plasma concentrations ...